keyboard_arrow_up

Tissue-Based Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology), Disease, Product & End-Users worth $3,924.01 Million by 2018

Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer. The market includes instruments, reagents and kits used to determine the stage, prognosis, and treatment course of the disease. Increasing global incidences of cancer, the adoption of tissue diagnostic products as companion diagnostics in personalized medicine for cancer and the rapidly aging global population are expected to be the three most important growth drivers for the global market.

The global tissue diagnostics market is expected to grow at a CAGR of close to 6.97% between 2013 and 2018, to reach $3,924.01 million in 2018.

 Tissue diagnostics finds primary application for diagnosis of cancer. As such, the hospital end-user segment commanded the largest share of the global market, while the research laboratories end-user segment is poised to grow at the highest CAGR between 2013 and 2018. The use of tissue diagnostic products for research purposes is expected to remain low.

 The report provides a granular understanding of the market. It segments the global tissue diagnostics market by technology, disease, product, end user, and geography. Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the market included in this report. The IHC technology segment commanded the largest share of the global market and is also poised to grow at the highest CAGR between 2013 and 2018, owing to its increasing use as companion diagnostics in personalized medicine for cancer.

 For Customization of Report: http://www.marketsandmarkets.com/requestCustomization.asp?id=1063949

 The disease segments included in this report are breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other diseases segments. The breast cancer disease segment commanded the largest share of the global market, and is also poised to grow at the highest CAGR between 2013 and 2018, due to the sharp increase in the incidences of disease owing to lifestyle changes and environmental factors.

 The end-user segments of the tissue diagnostics market included in this report are hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users like reference laboratories. The hospital end-user segment commanded the largest share of the global market, while the research laboratories end-user segment is poised to grow at the highest CAGR between 2013 and 2018.

 Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1063949

 The Americas accounted for the largest share of the global market. The Patient Protection and Affordable Care Act (PPACA) introduced in the U.S. in March 2010 is expected to expand insurance access to more than 30 million U.S. citizens. This is expected to drive the demand for advanced cancer diagnostics, including tissue diagnostics, in this important geographic segment. On the other hand, the BRIC and RoW geographic segments are expected to grow rapidly at a higher CAGR in the forecast period between 2013 and 2018, owing to the large and rapidly aging population, and large untapped potential of these markets.

 The major players in the tissue diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.). Other important players in this market are Biogenex Laboratories (U.S.), Sigma-Aldrich (U.S.), Cell Signaling Technology (U.S.), Bio SB (U.S.) and Life Technologies (U.S.).

 Browse related reports:

Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportunities, Competitor Analysis & Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

 In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2017
http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

 About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets